Latest stories on VTRS
Viatris: Strong Cash Generation And Pipeline Progress Keep The Re-Rating Story Alive
Seeking Alpha67 · bullishearnings
Leerink sees growth for Viatris, starts at Outperform
The Fly61 · neutralanalyst
Viatris initiated with an Outperform at Leerink
The Fly61 · neutralanalyst
Viatris Inc. stock falls Tuesday, underperforms market
MarketWatch42 · neutralgeneral
Viatris price target raised to $20 from $15 at Argus
The Fly61 · neutralanalyst
Citizens reiterates Opus Genetics stock rating on Viatris partnership potential
Investing.com Analyst Ratings56 · neutralanalyst
Cavendish reiterates 'buy' rating on Shield Therapeutics after US deal with Viatris
Yahoo Top63 · neutralm&a
Viatris Inc. stock rises Friday, outperforms market
MarketWatch56 · neutralgeneral
Viatris Inc. stock rises Friday, outperforms market
MarketWatch56 · neutralgeneral
Viatris (VTRS) is Selling Tyrvaya, but Could Harrow (HROW) Turn it Into a Growth Engine?
Yahoo Top63 · neutralm&a
Viatris (VTRS) Q2 2026 Earnings Call Transcript
Yahoo Top68 · bullishearnings
Viatris (VTRS) Q2 2026 Earnings Call Transcript
The Motley Fool68 · bullishearnings
Viatris Inc. stock falls Wednesday, underperforms market
MarketWatch42 · neutralgeneral
Viatris Earnings Call: Guidance Raised Amid Headwinds
TipRanks56 · neutralearnings
Viatris raises 2026 outlook while targeting $500M peak sales for fast-acting meloxicam
Seeking Alpha67 · bullishproduct/pr
Viatris Inc. (VTRS) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Viatris Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Viatris Boosts 2026 Guidance as Revenue and Cash Flow Strengthen; Balance Sheet Improvement Continues
August 6, 2026
MarketChameleon73 · bullishearnings
Viatris Inc (VTRS) files 8-K
SEC 8-K50 · neutralgeneral
Viatris posts Q2 beat; sells eye drug Tyrvaya to Harrow for up to $100M
Seeking Alpha63 · neutralm&a
Viatris Non-GAAP EPS of $0.69 beats by $0.09, revenue of $3.75B beats by $80M
Seeking Alpha68 · bullishearnings
Viatris Reports Second-Quarter 2026 Financial Results
PR Newswire50 · neutralearnings
Viatris Q2 preview: Analysts see profits softening amid pressure on generics business
Seeking Alpha42 · neutralearnings
Is Wall Street Bullish or Bearish on Viatris Stock?
Barchart56 · neutralanalyst
Is Wall Street Bullish or Bearish on Viatris Stock?
Yahoo Finance56 · neutralanalyst